These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 12930598)

  • 1. Interferon-alpha and autoimmune thyroid disease.
    Prummel MF; Laurberg P
    Thyroid; 2003 Jun; 13(6):547-51. PubMed ID: 12930598
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum CXCL10 levels and occurrence of thyroid dysfunction in patients treated with interferon-alpha therapy for hepatitis C virus-related hepatitis.
    Rotondi M; Minelli R; Magri F; Leporati P; Romagnani P; Baroni MC; Delsignore R; Serio M; Chiovato L
    Eur J Endocrinol; 2007 Apr; 156(4):409-14. PubMed ID: 17389454
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epidemiology, risk factors and prognosis of Interferon alpha induced thyroid disorders. A Prospective Clinical Study.
    Obołończyk Ł; Siekierska-Hellmann M; Wiśniewski P; Lewczuk A; Berendt-Obołończyk M; Lakomy A; Michalska Z; Radowska D; Moszkowska G; Bianek-Bodzak A; Sworczak K
    Postepy Hig Med Dosw (Online); 2017 Sep; 71(0):842-849. PubMed ID: 29039351
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Autoimmune thyroid dysfunction induced by interferon-alpha treatment for chronic hepatitis C: screening and monitoring recommendations.
    Ward DL; Bing-You RG
    Endocr Pract; 2001; 7(1):52-8. PubMed ID: 11250770
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association between human leukocyte antigen (HLA) and interferon- induced thyroid diseases in four patients with HCV-related chronic hepatitis.
    Labbadia G; Martocchia A; Mammarella A; Paoletti V; Rocco A; Benvenuto R; Antonella P; Rosaria D; Trabace S; Musca A; Falaschi P
    Neuro Endocrinol Lett; 2005 Apr; 26(2):109-12. PubMed ID: 15855880
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparison of the prevalence of autoantibodies in individuals with chronic hepatitis C and those with autoimmune hepatitis: the role of interferon in the development of autoimmune diseases.
    Bayraktar Y; Bayraktar M; Gurakar A; Hassanein TI; Van Thiel DH
    Hepatogastroenterology; 1997; 44(14):417-25. PubMed ID: 9164512
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prospective study on thyroid autoimmunity and dysfunction related to chronic hepatitis C and interferon therapy.
    Custro N; Montalto G; Scafidi V; Soresi M; Gallo S; Tripi S; Notarbartolo A
    J Endocrinol Invest; 1997; 20(7):374-80. PubMed ID: 9309534
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of thyroid autoimmunity after administration of recombinant human interferon-alpha 2b for chronic viral hepatitis.
    Chung YH; Shong YK
    Am J Gastroenterol; 1993 Feb; 88(2):244-7. PubMed ID: 8424429
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Autoimmune thyroid disease induced by interferon therapy].
    Murakami M; Kakizaki S; Takayama H; Takagi H; Mori M
    Nihon Rinsho; 1999 Aug; 57(8):1779-83. PubMed ID: 10483250
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incidence of autoimmune thyroiditis in interferon-alpha treated and untreated patients with chronic hepatitis C virus infection.
    Rocco A; Gargano S; Provenzano A; Nardone M; De Sanctis GM; Altavilla N; Chircu LV; Grimaldi F
    Neuro Endocrinol Lett; 2001; 22(1):39-44. PubMed ID: 11335878
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Side effects during interferon-alpha therapy of hepatitis C with special consideration of thyroid dysfunction].
    Obołończyk L; Obołończyk L; Siekierska-Hellmann M; Sworczak K
    Postepy Hig Med Dosw (Online); 2007 Jun; 62():309-21. PubMed ID: 18583950
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence of HCV antibodies in autoimmune thyroid disease.
    Testa A; Castaldi P; Fant V; Fiore GF; Grieco V; De Rosa A; Pazardjiklian MG; De Rosa G
    Eur Rev Med Pharmacol Sci; 2006; 10(4):183-6. PubMed ID: 16910348
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Interferon-alpha-induced disorders of thyroid function. A retrospective analysis of the literature and personal experiences].
    Weissel M; Templ E; Gisslinger H
    Acta Med Austriaca; 1995; 22(1-2):1-5. PubMed ID: 7645363
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thyroid autoimmunity and dysfunction associated with type I interferon therapy.
    Monzani F; Caraccio N; Dardano A; Ferrannini E
    Clin Exp Med; 2004 Apr; 3(4):199-210. PubMed ID: 15103510
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thyroid abnormalities in chronic viral hepatitis and their relationship to interferon alfa therapy.
    Deutsch M; Dourakis S; Manesis EK; Gioustozi A; Hess G; Horsch A; Hadziyannis S
    Hepatology; 1997 Jul; 26(1):206-10. PubMed ID: 9214471
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential effects of human interferon alpha and interferon gamma on xenografted human thyroid tissue in severe combined immunodeficient mice and nude mice.
    Kawai K; Enomoto T; Fornasier V; Resetkova E; Volpé R
    Proc Assoc Am Physicians; 1997 Mar; 109(2):126-35. PubMed ID: 9069581
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thyrocyte class I and class II upregulation is a secondary phenomenon and does not contribute to the pathogenesis of autoimmune thyroid disease.
    Yue SJ; Enomoto T; Matsumoto Y; Kawai K; Volpé R
    Thyroid; 1998 Sep; 8(9):755-63. PubMed ID: 9777745
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Environmental triggers of thyroiditis: hepatitis C and interferon-α.
    Menconi F; Hasham A; Tomer Y
    J Endocrinol Invest; 2011 Jan; 34(1):78-84. PubMed ID: 21297381
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interferon-α Triggers Autoimmune Thyroid Diseases via Lysosomal-Dependent Degradation of Thyroglobulin.
    Faustino LC; Lombardi A; Madrigal-Matute J; Owen RP; Libutti SK; Tomer Y
    J Clin Endocrinol Metab; 2018 Oct; 103(10):3678-3687. PubMed ID: 30113675
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Interferon alpha antibodies show no cross reactions with typical autoantibodies].
    Görg S; Klouche M; Wilhelm D; Kirchner H
    Immun Infekt; 1993 Apr; 21 Suppl 1():54-6. PubMed ID: 8344695
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.